OHSU has been invited to nominate one applicant for the Dana Foundation’s neuroimaging research program, which focuses on improving human brain and brain-immune functioning to promote health and prevent and treat disease. Funding of up to $200,000 over three years supports pilot testing by investigators, who are early in their research careers, to enable them to pursue promising, high-risk, and innovative ideas that have a direct clinical application. The pilot data are anticipated to help increase competitiveness for seeking larger-scale support from other funders.
Investigations need to be applicable to human brain or brain-immune functioning or malfunctioning. To be considered for funding, submitted proposals should focus on imaging in patients or patient tissues, and healthy volunteers using either or both:
- Physiological and structural imaging – anatomical imaging of white or gray matter and measures of physiological functioning. These proposed studies should focus on patient-oriented clinical research.
- Cellular/molecular imaging – biochemical actions of specific brain cells, or their interactions with immune cells, which have direct clinical relevance to human health and disease. These studies may involve human tissues or animal models. Applications can involve the study of cells within neural circuits, using a combination of imaging and single cell electrical recording, if the techniques have already been developed.
The internal deadline for this funding opportunity has been extended to Monday, Feb. 8, at noon. Limited submission guidelines apply.